BioAtla, Inc.
BCAB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $29 | $118 | $321 | $678 |
| - Cash | $49 | $111 | $216 | $245 |
| + Debt | $1 | $2 | $4 | $5 |
| Enterprise Value | -$19 | $9 | $110 | $439 |
| Revenue | $11 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $10 | -$1 | -$1 | $0 |
| % Margin | 91.6% | – | – | 100% |
| EBITDA | -$73 | -$122 | -$105 | -$94 |
| % Margin | -663.8% | – | – | -37,627.6% |
| Net Income | -$70 | -$123 | -$105 | -$95 |
| % Margin | -634.3% | – | – | -38,160.8% |
| EPS Diluted | -1.44 | -2.58 | -2.74 | -2.76 |
| % Growth | 44.2% | 5.8% | 0.7% | – |
| Operating Cash Flow | -$72 | -$104 | -$90 | -$62 |
| Capital Expenditures | $0 | -$0 | -$0 | -$1 |
| Free Cash Flow | -$72 | -$104 | -$91 | -$63 |